Topic: Antibiotic-Resistant Bacteria.
Destination: Beginning with competitive funding calls to address unmet medical needs, CARB-X provides non-dilutive funding as well as scientific, regulatory and business support to product developers. Through life-saving innovation the goal is to keep the world prepared for dangerous bacterial infections. The CARB-X funding rounds have three distinct product themes: oral therapeutics, vaccines for neonatal sepsis and gonorrhea products.
Budget: Not indicated.
Duration: Not indicated.
Fill out the form below to receive more information: